. Counting costs. Patients will suffer from limits on Alzheimer's drugs. Nurs Stand. 2005 May 25-31;19(37):24-5. PubMed.


Please login to recommend the paper.


  1. This is sobering news from a national health service that makes tough choices on balancing costs for AD medications with data on their long-term as well as short-term efficacy.

Make a Comment

To make a comment you must login or register.